Literature DB >> 19502238

LFA-1 and CD2 synergize for the Erk1/2 activation in the Natural Killer (NK) cell immunological synapse.

Xiaodong Zheng1, Yanyan Wang, Haiming Wei, Rui Sun, Zhigang Tian.   

Abstract

Natural killer (NK) cell recognition and formation of a conjugate with target cells, followed by intracellular signal pathway activation and degradation of cytolytic granules, are essential for NK cell cytotoxicity. In this study, NK92 cells were used to investigate synapse formation and subsequent signaling after binding to the target cell. The binding rate of the NK92-target cell was associated with NK92 cell cytotoxicity. Confocal results showed that adhesion molecules, LFA-1 (CD11a) and CD2, accumulated at the interface of the NK92-K562 contact. Ligation with K562 cells activated the Erk1/2 signal pathway of NK92 cells. The blocking of the NK-target conjugate by EDTA or anti-CD11a or/and anti-CD2 antibody decreased the phosphorylation of Erk1/2 and NK cell cytotoxicity. Inhibition of Erk1/2 phosphorylation by the chemical inhibitor U0126 suppressed the cytolytic activity of NK92 cells, but had no effect on NK-target conjugate formation. Thus, conjugate formation of the NK92-target cell was prerequisite to NK cell activation, and subsequent signal transduction was also required for NK cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502238      PMCID: PMC2755852          DOI: 10.1074/jbc.M807053200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  A view to a kill: signals triggering cytotoxicity.

Authors:  Julie Y Djeu; Kun Jiang; Sheng Wei
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

2.  The mature activating natural killer cell immunologic synapse is formed in distinct stages.

Authors:  Jordan S Orange; K Eliza Harris; Milena M Andzelm; Markus M Valter; Raif S Geha; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

3.  JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.

Authors:  Changlin Li; Baoxue Ge; Matthew Nicotra; Joel N H Stern; Hernan D Kopcow; Xi Chen; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 4.  Natural killer cell receptors: the offs and ons of NK cell recognition.

Authors:  D H Raulet; W Held
Journal:  Cell       Date:  1995-09-08       Impact factor: 41.582

5.  CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells.

Authors:  Xi Chen; David S J Allan; Konrad Krzewski; Baoxue Ge; Hernan Kopcow; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

6.  Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1).

Authors:  Sheryl E Kirwan; Deborah N Burshtyn
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

Review 7.  Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.

Authors:  T Tonn; S Becker; R Esser; D Schwabe; E Seifried
Journal:  J Hematother Stem Cell Res       Date:  2001-08

8.  Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92.

Authors:  G Maki; H G Klingemann; J A Martinson; Y K Tam
Journal:  J Hematother Stem Cell Res       Date:  2001-06

9.  Adhesion to target cells is disrupted by the killer cell inhibitory receptor.

Authors:  D N Burshtyn; J Shin; C Stebbins; E O Long
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

10.  Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase C-gamma following CD2 stimulation.

Authors:  Hiroshi Inoue; Michihiko Miyaji; Atsushi Kosugi; Masakazu Nagafuku; Toshiro Okazaki; Tsuneyo Mimori; Ryuichi Amakawa; Shirou Fukuhara; Naochika Domae; Eda T Bloom; Hisanori Umehara
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

View more
  14 in total

1.  Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.

Authors:  Wei Wang; Huaijian Guo; Jianlin Geng; Xiaodong Zheng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

2.  Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.

Authors:  Eun-Ok Kim; Tae-Jin Kim; Nayoung Kim; Sung Tae Kim; Vinay Kumar; Kyung-Mi Lee
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

3.  Glucocorticoid dysregulation of natural killer cell function through epigenetic modification.

Authors:  Karen Krukowski; Justin Eddy; Kelly Loster Kosik; Teresa Konley; Linda Witek Janusek; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2010-07-23       Impact factor: 7.217

4.  Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.

Authors:  Jennifer A A Gubbels; Brian Gadbaw; Ilia N Buhtoiarov; Sachi Horibata; Arvinder K Kapur; Dhara Patel; Jacquelyn A Hank; Stephen D Gillies; Paul M Sondel; Manish S Patankar; Joseph Connor
Journal:  Cancer Immunol Immunother       Date:  2011-07-27       Impact factor: 6.968

5.  Practical NK cell phenotyping and variability in healthy adults.

Authors:  Laura S Angelo; Pinaki P Banerjee; Linda Monaco-Shawver; Joshua B Rosen; George Makedonas; Lisa R Forbes; Emily M Mace; Jordan S Orange
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

6.  The effect of different anesthetics on tumor cytotoxicity by natural killer cells.

Authors:  Kazumasa Tazawa; Sophia Koutsogiannaki; Matthew Chamberlain; Koichi Yuki
Journal:  Toxicol Lett       Date:  2016-12-08       Impact factor: 4.372

Review 7.  Improving natural killer cell cancer immunotherapy.

Authors:  Melissa M Berrien-Elliott; Rizwan Romee; Todd A Fehniger
Journal:  Curr Opin Organ Transplant       Date:  2015-12       Impact factor: 2.640

8.  CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

Authors:  Julia A Wagner; Maximillian Rosario; Rizwan Romee; Melissa M Berrien-Elliott; Stephanie E Schneider; Jeffrey W Leong; Ryan P Sullivan; Brea A Jewell; Michelle Becker-Hapak; Timothy Schappe; Sara Abdel-Latif; Aaron R Ireland; Devika Jaishankar; Justin A King; Ravi Vij; Dennis Clement; Jodie Goodridge; Karl-Johan Malmberg; Hing C Wong; Todd A Fehniger
Journal:  J Clin Invest       Date:  2017-10-03       Impact factor: 14.808

9.  Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.

Authors:  Chiara F Magnani; Giada Alberigo; Rosa Bacchetta; Giorgia Serafini; Marco Andreani; Maria Grazia Roncarolo; Silvia Gregori
Journal:  Eur J Immunol       Date:  2011-05-13       Impact factor: 5.532

10.  Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model.

Authors:  U Erben; N N Pawlowski; M M Heimesaat; C Loddenkemper; K Doerfel; S Spieckermann; B Siegmund; A A Kühl
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.